Select Page

Arab Pharmaceuticals reports EGP 49 million net profits

Arab Drug Company for Pharmaceuticals and Chemical Industries (ADCO), Egypt, reported net profits after-tax of EGP 49.5 million during the first half of the fiscal year 2021-2022, compared to EGP 58.3 million during the same period last fiscal year.

That means that the company’s profits are down about 15% YoY.

The company’s revenues decreased to EGP 280.6 million during the six months ended last December, compared to EGP 291.2 million during the same period last fiscal year.